MeiraGTx Holdings PLCNASDAQ:MGTX
- LAST PRICE4.2500
- TODAY'S CHANGE (%)0.0800 (1.9185%)
- Bid / Lots4.0500/ 5
- Ask / Lots4.5500/ 50
- Open / Previous Close4.2400 / 4.1700
- Day Range
- 52 Week Range
- Volume159,808
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGTX |
|---|---|---|
| 09:32 ET | 1298 | 4.24 |
| 09:34 ET | 1750 | 4.2341 |
| 09:36 ET | 200 | 4.2757 |
| 09:38 ET | 1765 | 4.29 |
| 09:43 ET | 1000 | 4.3 |
| 09:50 ET | 100 | 4.29 |
| 10:06 ET | 1100 | 4.3 |
| 10:10 ET | 4401 | 4.3 |
| 10:12 ET | 1701 | 4.34 |
| 10:14 ET | 6561 | 4.39 |
| 10:15 ET | 778 | 4.37 |
| 10:17 ET | 100 | 4.36 |
| 10:28 ET | 100 | 4.35 |
| 10:33 ET | 100 | 4.34 |
| 10:42 ET | 8011 | 4.335 |
| 10:44 ET | 450 | 4.3 |
| 10:46 ET | 1812 | 4.2684 |
| 10:48 ET | 100 | 4.255 |
| 10:57 ET | 11729 | 4.22 |
| 11:13 ET | 2000 | 4.225 |
| 11:18 ET | 1314 | 4.2 |
| 11:20 ET | 326 | 4.19 |
| 11:24 ET | 2726 | 4.2 |
| 11:27 ET | 100 | 4.21 |
| 11:29 ET | 2100 | 4.19 |
| 11:38 ET | 595 | 4.18 |
| 11:44 ET | 1590 | 4.19 |
| 11:45 ET | 1005 | 4.1879 |
| 11:47 ET | 7800 | 4.17 |
| 11:49 ET | 750 | 4.16 |
| 11:51 ET | 800 | 4.165 |
| 11:56 ET | 2800 | 4.2 |
| 12:00 ET | 752 | 4.2 |
| 12:02 ET | 100 | 4.21 |
| 12:25 ET | 200 | 4.22 |
| 12:59 ET | 100 | 4.23 |
| 01:32 ET | 1000 | 4.26 |
| 01:33 ET | 100 | 4.255 |
| 01:39 ET | 6700 | 4.26 |
| 01:48 ET | 804 | 4.26 |
| 01:55 ET | 100 | 4.23 |
| 02:06 ET | 1060 | 4.22 |
| 02:08 ET | 200 | 4.22 |
| 02:11 ET | 500 | 4.23 |
| 02:20 ET | 300 | 4.22 |
| 02:24 ET | 100 | 4.23 |
| 02:26 ET | 100 | 4.21 |
| 02:38 ET | 633 | 4.215 |
| 02:40 ET | 747 | 4.21 |
| 02:42 ET | 100 | 4.22 |
| 02:44 ET | 1000 | 4.225 |
| 02:45 ET | 100 | 4.23 |
| 02:49 ET | 200 | 4.22 |
| 02:56 ET | 409 | 4.23 |
| 03:00 ET | 200 | 4.23 |
| 03:02 ET | 100 | 4.23 |
| 03:05 ET | 200 | 4.22 |
| 03:07 ET | 300 | 4.22 |
| 03:12 ET | 300 | 4.22 |
| 03:20 ET | 800 | 4.22 |
| 03:23 ET | 324 | 4.22 |
| 03:25 ET | 100 | 4.22 |
| 03:30 ET | 100 | 4.22 |
| 03:32 ET | 100 | 4.23 |
| 03:34 ET | 100 | 4.235 |
| 03:36 ET | 700 | 4.25 |
| 03:38 ET | 211 | 4.25 |
| 03:39 ET | 411 | 4.24 |
| 03:41 ET | 500 | 4.25 |
| 03:43 ET | 311 | 4.25 |
| 03:45 ET | 200 | 4.24 |
| 03:48 ET | 1400 | 4.26 |
| 03:50 ET | 1100 | 4.26 |
| 03:52 ET | 900 | 4.245 |
| 03:54 ET | 730 | 4.245 |
| 03:56 ET | 800 | 4.26 |
| 03:57 ET | 7168 | 4.25 |
| 03:59 ET | 27822 | 4.25 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MeiraGTx Holdings PLC | 328.0M | -2.8x | --- |
Uniqure NV | 275.6M | -1.0x | --- |
TScan Therapeutics Inc | 304.1M | -5.5x | --- |
XOMA Royalty Corp | 339.2M | -13.0x | --- |
Ocugen Inc | 348.3M | -6.8x | --- |
AC Immune SA | 314.6M | -4.2x | --- |
Company Information
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Contact Information
- Headquarters
- 450 E 29th St Fl 15NEW YORK, NY, United States 10016-8367
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Keith Harris
- President, Chief Executive Officer, Director
- Alexandria Forbes
- Chief Financial Officer, Chief Operating Officer
- Richard Giroux
- General Counsel, Secretary
- Robert Wollin
- Chief Development Officer
- Stuart Naylor
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $328.0M |
|---|---|
Revenue (TTM) | $8.1M |
Shares Outstanding | 77.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.28 |
EPS | $-1.49 |
Book Value | $2.17 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 40.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,083.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
